| SCAI clinical expert consensus statement on the classification of cardiogenic shock This document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019 |
92 |
| Improved Outcomes Associated with the use of Shock Protocols: Updates from the National Cardiogenic Shock Initiative |
42 |
| Feasibility of early mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock: The Detroit cardiogenic shock initiative |
32 |
| SCAI consensus guidelines for device selection in femoral-popliteal arterial interventions |
20 |
| Length of stay following percutaneous coronary intervention: An expert consensus document update from the society for cardiovascular angiography and interventions |
20 |
| Primary outcomes and mechanism of action of intravascular lithotripsy in calcified, femoropopliteal lesions: Results of Disrupt PAD II |
18 |
| Comparison of local versus general anesthesia in patients undergoing transcatheter aortic valve replacement: A meta-analysis |
17 |
| Validating a prediction modeling tool for left ventricular outflow tract (LVOT) obstruction after transcatheter mitral valve replacement (TMVR) |
17 |
| Impact and trends of intravascular imaging in diagnostic coronary angiography and percutaneous coronary intervention in inpatients in the United States |
17 |
| Patient preference for radial versus femoral vascular access for elective coronary procedures: The PREVAS study |
16 |
| Transcatheter valve-in-valve versus redo surgical aortic valve replacement for the treatment of degenerated bioprosthetic aortic valve: A systematic review and meta-analysis |
16 |
| Diagnostic performance of quantitative flow ratio in prospectively enrolled patients: An individual patient-data meta-analysis |
15 |
| Role of Transcatheter patent ductus arteriosus closure in extremely low birth weight infants |
14 |
| First human implant of the Alterra Adaptive Prestent(TM): A new self-expanding device designed to remodel the right ventricular outflow tract |
14 |
| Supra-annular structure assessment for self-expanding transcatheter heart valve size selection in patients with bicuspid aortic valve |
14 |
| Impact of percutaneous femoral arteriotomy closure using the MANTA(TM) device on vascular and bleeding complications after transcatheter aortic valve replacement |
13 |
| Drug-coated balloon versus plain old balloon angioplasty in femoropopliteal disease: An updated meta-analysis of randomized controlled trials |
13 |
| SAPIEN valve for percutaneous transcatheter pulmonary valve replacement without pre-stenting: A multi-institutional experience |
13 |
| Transcatheter versus surgical aortic valve replacement in patients at low surgical risk: A meta-analysis of randomized trials and propensity score matched observational studies |
13 |
| A randomized comparison of modified subcutaneous Z-stitch versus manual compression to achieve hemostasis after large caliber femoral venous sheath removal |
12 |
| Impact of prosthesis-iteration evolution and sizing practice on the incidence of prosthesis-patient mismatch after transcatheter aortic valve replacement |
11 |
| Long-term efficacy of drug coated balloons compared with new generation drug-eluting stents for the treatment of de novo coronary artery lesions |
11 |
| Feasibility of coronary angiography and percutaneous coronary intervention after transcatheter aortic valve replacement using a Medtronic self-expandable bioprosthetic valve |
11 |
| Stellarex drug-coated balloon for treatment of femoropopliteal arterial diseaseThe ILLUMENATE Global Study: 12-Month results from a prospective, multicenter, single-arm study |
11 |
| Initial results from the off-label use of the SAPIEN S3 valve for percutaneous transcatheter pulmonary valve replacement: A multi-institutional experience |
11 |
| Distal radial access for coronary angiography and percutaneous coronary intervention: A state-of-the-art review |
10 |
| Transseptal transcatheter mitral valve-in-valve: A step by step guide from preprocedural planning to postprocedural care |
10 |
| Hybrid coronary revascularization versus coronary artery bypass grafting in patients with multivessel coronary artery disease: A meta-analysis |
10 |
| Safety and clinical performance of a drug eluting absorbable metal scaffold in the treatment of subjects with de novo lesions in native coronary arteries: Pooled 12-month outcomes of BIOSOLVE-II and BIOSOLVE-III |
10 |
| The effectiveness and safety of the Impella ventricular assist device for high-risk percutaneous coronary interventions: A systematic review |
10 |
| The JUPITER registry: One-year outcomes of transapical aortic valve implantation using a second generation transcatheter heart valve for aortic regurgitation |
10 |
| Distal transradial artery access in the anatomical snuffbox for coronary angiography as an alternative access site for faster hemostasis |
10 |
| Quantitative flow ratio for immediate assessment of nonculprit lesions in patients with ST-segment elevation myocardial infarction-An iSTEMI substudy |
10 |
| Procedural trends, outcomes, and readmission rates pre-and post-FDA approval for MitraClip from the National Readmission Database (2013-14) |
9 |
| Treatment of infrapopliteal post-PTA dissection with tack implants: 12-month results from the TOBA-BTK study |
9 |
| Predictors of in-hospital effectiveness and complications of rotational atherectomy (from the ORPKI Polish National Registry 2014-2016) |
9 |
| The interplay between permanent pacemaker implantation and mortality in patients treated by transcatheter aortic valve implantation: A systematic review and meta-analysis |
9 |
| Impact of subintimal plaque modification procedures on health status after unsuccessful chronic total occlusion angioplasty |
9 |
| CYP2C19 pharmacogenetics versus standard of care dosing for selecting antiplatelet therapy in patients with coronary artery disease: A meta-analysis of randomized clinical trials |
9 |
| Implementation of the transradial approach as an alternative vascular access for transcatheter aortic valve replacement guidance: Experience from a high-volume center |
8 |
| Early collapse causing stenosis in a resorbable magnesium scaffold |
8 |
| Classification scheme for ductal morphology in cyanotic patients with ductal dependent pulmonary blood flow and association with outcomes of patent ductus arteriosus stenting |
8 |
| Does mild paravalvular regurgitation post transcatheter aortic valve implantation affect survival? A meta-analysis |
8 |
| Prevalence, correlates, and impact of coronary calcification on adverse events following PCI with newer-generation DES: Findings from a large multiethnic registry |
8 |
| Radiation-associated lens changes in the cardiac catheterization laboratory: Results from the IC-CATARACT (CATaracts Attributed to RAdiation in the CaTh lab) study |
8 |
| Revascularization of coronary chronic total occlusions with subintimal tracking and reentry followed by deferred stenting: Experience from a high-volume referral center |
8 |
| Mid-term outcomes (up to 5 years) of percutaneous edge-to-edge mitral repair in the real-world according to regurgitation mechanism: A single-center experience |
7 |
| Outcomes and safety of same-day discharge after percutaneous coronary intervention: A 10-year single-center study |
7 |
| Predictive value of neutrophil to lymphocyte ratio in long-term outcomes of left main and/or three-vessel disease in patients with acute myocardial infarction |
7 |
| Tricuspid regurgitation as a complication of Edwards Sapien XT valve implantation in pulmonary position a problem to deal with |
7 |
